Adjuvant immune checkpoint inhibitors associated with higher recurrence-free survival in postoperative hepatocellular carcinoma (PREVENT): a prospective, multicentric cohort study.
Le LiPei-Sheng WuXiu-Mei LiangKang ChenGuan-Lan ZhangQi-Bin SuRong-Rui HuoRong-Wei XieShan HuangLiang MaJian-Hong ZhongPublished in: Journal of gastroenterology (2023)
ICIs alone or with TKIs may improve RFS of patients at high risk of HCC recurrence after curative resection.